Literature DB >> 10867238

The fib locus in Streptococcus pneumoniae is required for peptidoglycan crosslinking and PBP-mediated beta-lactam resistance.

B Weber1, K Ehlert, A Diehl, P Reichmann, H Labischinski, R Hakenbeck.   

Abstract

Penicillin resistance in pneumococci is mediated by modified penicillin-binding proteins (PBPs) that have decreased affinity to beta-lactams. In high-level penicillin-resistant transformants of the laboratory strain Streptococcus pneumoniae R6 containing various combinations of low-affinity PBPs, disruption of the fib locus results in a collapse of PBP-mediated resistance. In addition, crosslinked muropeptides are highly reduced. The fib operon consists of two genes, fibA and fibB, homologous to Staphylococcus aureus femA/B which are also required for expression of methicillin resistance in this organism. FibA and FibB belong to a family of proteins of Gram-positive bacteria involved in the formation of interpeptide bridges, thus representing interesting new targets for antimicrobial compounds for this group of pathogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867238     DOI: 10.1111/j.1574-6968.2000.tb09172.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  23 in total

1.  Identification of the UDP-MurNAc-pentapeptide:L-alanine ligase for synthesis of branched peptidoglycan precursors in Enterococcus faecalis.

Authors:  A Bouhss; N Josseaume; D Allanic; M Crouvoisier; L Gutmann; J L Mainardi; D Mengin-Lecreulx; J van Heijenoort; M Arthur
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 2.  FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and beta-lactam resistance in gram-positive cocci.

Authors:  S Rohrer; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 3.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

4.  Evolution and virulence of serogroup 6 pneumococci on a global scale.

Authors:  D Ashley Robinson; David E Briles; Marilyn J Crain; Susan K Hollingshead
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

5.  Site-specific mutagenesis analysis of PBP 1A from a penicillin-cephalosporin-resistant pneumococcal isolate.

Authors:  Anthony M Smith; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 6.  Roles of tRNA in cell wall biosynthesis.

Authors:  Kiley Dare; Michael Ibba
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-01-19       Impact factor: 9.957

7.  Amino acid mutations essential to production of an altered PBP 2X conferring high-level beta-lactam resistance in a clinical isolate of Streptococcus pneumoniae.

Authors:  Anthony M Smith; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

8.  Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of beta-lactam resistance.

Authors:  Laurent Chesnel; Raphaël Carapito; Jacques Croizé; Otto Dideberg; Thierry Vernet; André Zapun
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  The CiaRH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in beta-lactam resistance.

Authors:  Thorsten Mascher; Manuel Heintz; Dorothea Zähner; Michelle Merai; Regine Hakenbeck
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

Review 10.  Resistance to antibiotics targeted to the bacterial cell wall.

Authors:  I Nikolaidis; S Favini-Stabile; A Dessen
Journal:  Protein Sci       Date:  2014-01-17       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.